MAIA Biotechnology, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (2)

View All

Latest Posts

About This Stock More About This Stock
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Article By: Vision And Value
Thursday, February 22, 2024 6:15 AM EDT
MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.
In this article: MAIA Also: LLY, MRK, NVS, ALPMY, BAYRY, GERN, REGN, TEVA, KURA, IOVA, ZNTL
Read
Opening Day: Immune-Oncology Company MAIA Biotechnology Drops In Market Debut
Article By: The Fly
Saturday, July 30, 2022 1:00 PM EDT
Shares of immune-oncology company MAIA Biotechnology dropped almost 15% in the company's trading debut on Thursday after the IPO was priced at the low end of expectations. On the flip side, ECB Bancorp's stock jumped over 40% in its market debut.
In this article: MGAM, MAIA, ECBK Also: SEAC, AMZN, UBER, DASH
Read
All Posts

Latest Tweets for $MAIA

No tweets yet!

PARTNER HEADLINES

$MAIA

Comments Status Updates
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Frank Underwood • 2/24/2024 10:22:34 PM

Great read on $MAIA

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Dick Kaplan • 2/23/2024 7:25:55 AM

This is an impressive and quite thorough analysis that leads to me to want to buy $MAIA.  But it begs the question... do you have a any relationship with the company or are you being compensated by the company in any way?  Your bio is quite sparse.

1 to 2 of 2 comments